| CNPEX | JESSX | CNPEX / JESSX | |
| Total Expense Ratio | 0.98 | 1.36 | 72% |
| Annual Report Gross Expense Ratio | 0.98 | 5.70 | 17% |
| Fund Existence | 24 years | 6 years | - |
| Gain YTD | 7.943 | 15.131 | 52% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 2500 | 10% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 166B | 114M | 145,614% |
| Annual Yield % from dividends | 0.75 | 0.09 | 828% |
| Returns for 1 year | 8.39 | 14.92 | 56% |
| Returns for 3 years | 42.41 | 61.70 | 69% |
| Returns for 5 years | 14.49 | 40.46 | 36% |
| Returns for 10 years | 110.33 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FNNEX | 87.03 | 0.73 | +0.85% |
| American Funds New Economy 529-F-3 | |||
| FBDIX | 210.12 | 1.57 | +0.75% |
| Franklin Biotechnology Discovery A | |||
| HEOSX | 20.14 | 0.09 | +0.45% |
| Hartford Climate Opportunities R4 | |||
| MBAIX | 34.24 | 0.14 | +0.41% |
| NYLI Balanced Class I | |||
| GIDWX | 20.47 | 0.07 | +0.34% |
| Goldman Sachs US Eq Div and Premium R6 | |||